Strategic acquisition expands MIRA's pipeline with SKNY-1 ... therapy that has the potential to improve patient outcomes. Weight Loss: A $150 Billion Market Opportunity The global weight loss ...

MIRA Pharmaceuticals to acquire SKNY Pharmaceuticals, integrating SKNY-1, a preclinical drug for weight loss and smoking cessation. The deal includes a $5 million capital infusion into MIRA ...